India already has talent, digital infrastructure, entrepreneurial energy, clinical expertise, and policy momentum. The next phase demands coordinated execution and building institutions that can hold the ecosystem together over time
With over three decades of extensive industry experience, Ramesh Juneja brings a strong track record of building and scaling large businesses
The acquisition marks Anupam Rasayan’s strategic entry into the pharmaceutical formulations segment
Expands Davaindia network to 2,579 stores
Q4FY26 revenue rises 13.6% to Rs. 14,560 crore; quarterly net profit jumps 26.2% to Rs. 2,714 crore driven by India business and Innovative Medicines growth
Eris Lifesciences posts sharp profit surge in FY26 driven by strong diabetes portfolio growth
She brings extensive expertise in managing global and domestic procurement operations
Combined company targets Rs. 2,500–3,000 crore revenue by 2030; new sterile and OSD plants to begin operations by August 2026
Growth was driven by expansion across key business segments, improving efficiencies, and sustained demand across institutional and retail channels
Subscribe To Our Newsletter & Stay Updated
